Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Human Immunodeficiency Virus | Research article

Correlates of nonadherence to key population-led HIV pre-exposure prophylaxis services among Thai men who have sex with men and transgender women

Authors: Pich Seekaew, Ezie Nguyen, Thanthip Sungsing, Jureeporn Jantarapakde, Supabhorn Pengnonyang, Deondara Trachunthong, Pravit Mingkwanrungruang, Waraporn Sirisakyot, Pattareeya Phiayura, Phubet Panpet, Phathranis Meekrua, Nanthika Praweprai, Fonthip Suwan, Supakarn Sangtong, Pornpichit Brutrat, Tashada Wongsri, Panus Rattakittvijun Na Nakorn, Stephen Mills, Matthew Avery, Ravipa Vannakit, Praphan Phanuphak, Nittaya Phanuphak

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

Based on government estimates from the Asian Epidemic Model, new infections among men who have sex with men (MSM) and transgender women (TGW) in Thailand are forecast to proportionally increase over time. Daily oral Pre-exposure prophylaxis (PrEP) protects against HIV acquisition when used as prescribed. The “Princess PrEP” program is the first key population-led (PrEP) initiative under Thai royal patronage with an aim to scale up countrywide implementation of PrEP.

Methods

Retention in and adherence to key population-led HIV PrEP services among HIV-uninfected Thai MSM and TGW was examined in four provinces: Bangkok, Chonburi, Chiang Mai, and Songkhla. HIV, HBsAg, creatinine tests, and self-administered questionnaires were performed during baseline measures. Participants were followed up after month 1, at month 3, then every 3 months. Correlates of nonadherence and loss to follow up at 1 month were assessed using linear regression models.

Results

37.4% of the participants reported low adherence to services (≤ 3 pills/week or missed clinic schedule at month 1). Factors associated with low adherence included younger age (25 years and under) (adjusted odds ratio (aOR): 1.49, 95% confidence interval (95% CI: 1.01–2.21, p = 0.044), being a TGW (aOR: 2.2, 95% CI: 1.27–3.83, p = 0.005), and whether the participant had not previously accessed services at the clinic (aOR = 1.68, 95% CI: 1.03–2.76, p = 0.04). Additionally, participants in Chonburi (the only TGW site) showed significantly lower adherence than those in the other three provinces (aOR: 2.91, 95% CI: 1.55–5.45, p = 0.001).

Conclusion

Urgent, innovative interventions for early PrEP adherence support among vulnerable sub-populations such as younger users, TGW, and new clients are needed to maximize prevention strategy in Thailand.
Appendix
Available only for authorised users
Literature
5.
go back to reference Lee D, Vielemeyer O, Sellier P, Lafuente-lafuente C, Roques P, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99.CrossRef Lee D, Vielemeyer O, Sellier P, Lafuente-lafuente C, Roques P, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99.CrossRef
6.
go back to reference Molina J, Capitant C, Spire B, Pialoux G, Cotte L, Charreau C, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373:2237–46.CrossRef Molina J, Capitant C, Spire B, Pialoux G, Cotte L, Charreau C, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373:2237–46.CrossRef
7.
go back to reference Zablotska I, Grulich A, Phanuphak N, Anand T, Janyam S, Poonkasetwattana M, et al. PrEP implementation in the asia-pacific region: opportunities, implementation and barriers. J Int AIDS Soc. 2016;19(S6):21119.PubMedPubMedCentral Zablotska I, Grulich A, Phanuphak N, Anand T, Janyam S, Poonkasetwattana M, et al. PrEP implementation in the asia-pacific region: opportunities, implementation and barriers. J Int AIDS Soc. 2016;19(S6):21119.PubMedPubMedCentral
8.
go back to reference van Griensven F, Phanuphak N, Srithanaviboonchai K. Biomedical HIV prevention research and epidemic control in Thailand: two sides of the same coin. Sex Health. 2014;11(2):180–99.CrossRef van Griensven F, Phanuphak N, Srithanaviboonchai K. Biomedical HIV prevention research and epidemic control in Thailand: two sides of the same coin. Sex Health. 2014;11(2):180–99.CrossRef
9.
go back to reference Colby D, Srithanaviboonchai K, Vanichseni S, Ongwandee S, Phanuphak N, Martin M, et al. HIV pre-exposure prophylaxis and health and community systems in the global south: Thailand case study. J Int AIDS Soc. 2015;18(4 Suppl 3):19953.PubMedPubMedCentral Colby D, Srithanaviboonchai K, Vanichseni S, Ongwandee S, Phanuphak N, Martin M, et al. HIV pre-exposure prophylaxis and health and community systems in the global south: Thailand case study. J Int AIDS Soc. 2015;18(4 Suppl 3):19953.PubMedPubMedCentral
10.
go back to reference Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among african women. N Engl J Med. 2012;367(5):411–22.CrossRef Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among african women. N Engl J Med. 2012;367(5):411–22.CrossRef
11.
go back to reference Martin M, Vanichseni S, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs. AIDS. 2015;29(7):819–24.CrossRef Martin M, Vanichseni S, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs. AIDS. 2015;29(7):819–24.CrossRef
12.
go back to reference Amico KR, Stirratt MJ. Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence. Clin Infect Dis. 2014;59(1):55.CrossRef Amico KR, Stirratt MJ. Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence. Clin Infect Dis. 2014;59(1):55.CrossRef
13.
go back to reference Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.CrossRef Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.CrossRef
14.
go back to reference Liu A, Glidden DV, Anderson PL, Amico KR, McMahan V, Mehrotra M, et al. Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study. J Acquir Immune Defic Syndr. 2014;67(5):528–37.CrossRef Liu A, Glidden DV, Anderson PL, Amico KR, McMahan V, Mehrotra M, et al. Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study. J Acquir Immune Defic Syndr. 2014;67(5):528–37.CrossRef
15.
go back to reference Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, et al. Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States. JAMA Pediatr. 2017;171(11):1063–71.CrossRef Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, et al. Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States. JAMA Pediatr. 2017;171(11):1063–71.CrossRef
19.
go back to reference Anand T, Nitpolprasert C, Kerr SJ, Muessig KE, Promthong S, Chomchey N, et al. A qualitative study of thai HIV-positive young men who have sex with men and transgender women demonstrates the need for eHealth interventions to optimize the HIV care continuum. AIDS Care. 2017;29(7):870–5.CrossRef Anand T, Nitpolprasert C, Kerr SJ, Muessig KE, Promthong S, Chomchey N, et al. A qualitative study of thai HIV-positive young men who have sex with men and transgender women demonstrates the need for eHealth interventions to optimize the HIV care continuum. AIDS Care. 2017;29(7):870–5.CrossRef
20.
go back to reference Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res. 2012;14(2):e51.CrossRef Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res. 2012;14(2):e51.CrossRef
21.
go back to reference Anand T, Nitpolprasert C, Ananworanich J, Pakam C, Nonenoy S, Jantarapakde J, et al. Innovative strategies using communications technologies to engage gay men and other men who have sex with men into early HIV testing and treatment in Thailand. J Virus Erad. 2015;1(2):111–5.PubMedPubMedCentral Anand T, Nitpolprasert C, Ananworanich J, Pakam C, Nonenoy S, Jantarapakde J, et al. Innovative strategies using communications technologies to engage gay men and other men who have sex with men into early HIV testing and treatment in Thailand. J Virus Erad. 2015;1(2):111–5.PubMedPubMedCentral
22.
go back to reference Mayer KH, Safren SA, Elsesser SA, Psaros C, Tinsley JP, Marzinke M, et al. Optimizing pre-exposure antiretroviral prophylaxis adherence in men who have sex with men: results of a pilot randomized controlled trial of “life-steps for PrEP.”. AIDS Behav. 2017;21(5):1350–60.CrossRef Mayer KH, Safren SA, Elsesser SA, Psaros C, Tinsley JP, Marzinke M, et al. Optimizing pre-exposure antiretroviral prophylaxis adherence in men who have sex with men: results of a pilot randomized controlled trial of “life-steps for PrEP.”. AIDS Behav. 2017;21(5):1350–60.CrossRef
23.
go back to reference Haberer JE. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice. Curr Opin HIV AIDS. 2016;11(1):10–7.CrossRef Haberer JE. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice. Curr Opin HIV AIDS. 2016;11(1):10–7.CrossRef
24.
go back to reference Baguso GN, Gay CL, Lee KA. Medication adherence among transgender women living with HIV. AIDS Care. 2016;28(8):976–81.CrossRef Baguso GN, Gay CL, Lee KA. Medication adherence among transgender women living with HIV. AIDS Care. 2016;28(8):976–81.CrossRef
25.
go back to reference Sevelius JM, Carrico A, Johnson MO. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care. 2010;21(3):256–64.CrossRef Sevelius JM, Carrico A, Johnson MO. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care. 2010;21(3):256–64.CrossRef
26.
go back to reference Sevelius JM, Keatley J, Calma N, Arnold E. ‘I am not a man’: trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11(7–8):1060–75.CrossRef Sevelius JM, Keatley J, Calma N, Arnold E. ‘I am not a man’: trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11(7–8):1060–75.CrossRef
27.
go back to reference Bauer GR, Hammond R, Travers R, Kaay M, Hohenadel KM, Boyce M. “I don’t think this is theoretical; this is our lives”: how erasure impacts health care for transgender people. J Assoc Nurses AIDS Care. 2009;20(5):348–61.CrossRef Bauer GR, Hammond R, Travers R, Kaay M, Hohenadel KM, Boyce M. “I don’t think this is theoretical; this is our lives”: how erasure impacts health care for transgender people. J Assoc Nurses AIDS Care. 2009;20(5):348–61.CrossRef
29.
go back to reference Beyrer C, Crago AL, Bekker LG, Butler J, Shannon K, Kerrigan D, et al. An action agenda for HIV and sex workers. Lancet. 2015;385(9964):287–301.CrossRef Beyrer C, Crago AL, Bekker LG, Butler J, Shannon K, Kerrigan D, et al. An action agenda for HIV and sex workers. Lancet. 2015;385(9964):287–301.CrossRef
30.
go back to reference Wilson D. HIV programs for sex workers: lessons and challenges for developing and delivering programs. PLoS Med. 2015;12(6):e1001808.CrossRef Wilson D. HIV programs for sex workers: lessons and challenges for developing and delivering programs. PLoS Med. 2015;12(6):e1001808.CrossRef
31.
go back to reference Mas de Xaxas M, O’Reilly K, Evans C, Higgins D, Gillies P, Jana S. Meeting community needs for HIV prevention and more: Intersectoral action for health in the Sonagachi red-light area of Kolkata. Geneva: WHO; 2008. Mas de Xaxas M, O’Reilly K, Evans C, Higgins D, Gillies P, Jana S. Meeting community needs for HIV prevention and more: Intersectoral action for health in the Sonagachi red-light area of Kolkata. Geneva: WHO; 2008.
32.
go back to reference Kerrigan DL, Fonner VA, Stromdahl S, Kennedy CE. Community empowerment among female sex workers is an effective HIV prevention intervention: a systematic review of the peer-reviewed evidence from low- and middle-income countries. AIDS Behav. 2013;17(6):1926–40.CrossRef Kerrigan DL, Fonner VA, Stromdahl S, Kennedy CE. Community empowerment among female sex workers is an effective HIV prevention intervention: a systematic review of the peer-reviewed evidence from low- and middle-income countries. AIDS Behav. 2013;17(6):1926–40.CrossRef
33.
go back to reference Agot K, Taylor D, Corneli AL, Wang M, Ambia J, Kashuba AD, et al. Accuracy of self-report and pill-count measures of adherence in the FEM-PrEP clinical trial: implications for future HIV-Prevention trials. AIDS Behav. 2014;19(5):743–51.CrossRef Agot K, Taylor D, Corneli AL, Wang M, Ambia J, Kashuba AD, et al. Accuracy of self-report and pill-count measures of adherence in the FEM-PrEP clinical trial: implications for future HIV-Prevention trials. AIDS Behav. 2014;19(5):743–51.CrossRef
34.
go back to reference Hendrix C, Gandhi M, Anderson P, Kamali A, Kibengo F, et al. Utility of different adherence measures for PrEP: patterns and incremental value. AIDS Behav. 2018;22(4):1165–73.CrossRef Hendrix C, Gandhi M, Anderson P, Kamali A, Kibengo F, et al. Utility of different adherence measures for PrEP: patterns and incremental value. AIDS Behav. 2018;22(4):1165–73.CrossRef
Metadata
Title
Correlates of nonadherence to key population-led HIV pre-exposure prophylaxis services among Thai men who have sex with men and transgender women
Authors
Pich Seekaew
Ezie Nguyen
Thanthip Sungsing
Jureeporn Jantarapakde
Supabhorn Pengnonyang
Deondara Trachunthong
Pravit Mingkwanrungruang
Waraporn Sirisakyot
Pattareeya Phiayura
Phubet Panpet
Phathranis Meekrua
Nanthika Praweprai
Fonthip Suwan
Supakarn Sangtong
Pornpichit Brutrat
Tashada Wongsri
Panus Rattakittvijun Na Nakorn
Stephen Mills
Matthew Avery
Ravipa Vannakit
Praphan Phanuphak
Nittaya Phanuphak
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-6645-0

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue